Cargando…
Spontaneous remission in diffuse large cell lymphoma: a case report
BACKGROUND: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission suggest that not yet fully characterized tumor-intrinsic and microenvironment mechanisms...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357409/ https://www.ncbi.nlm.nih.gov/pubmed/30709425 http://dx.doi.org/10.1186/s13256-018-1937-z |
_version_ | 1783391784873754624 |
---|---|
author | Snijder, J. Mihyawi, N. Frolov, A. Ewton, A. Rivero, G. |
author_facet | Snijder, J. Mihyawi, N. Frolov, A. Ewton, A. Rivero, G. |
author_sort | Snijder, J. |
collection | PubMed |
description | BACKGROUND: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission suggest that not yet fully characterized tumor-intrinsic and microenvironment mechanisms cooperate with spontaneous regression. CASE DESCRIPTION: Here, we report the case of an 88-year-old white woman with diffuse large b cell lymphoma (follicular lymphoma transformed) who achieved morphologic spontaneous remission 3 months after her diagnostic core biopsy. We examined 16 similar cases of diffuse large b cell lymphoma suggesting that spontaneous remission is preferentially observed in elderly patients soon after their biopsy microtrauma, especially if malignancies are Epstein–Barr virus driven and activated B-cell type. CONCLUSION: Our case and reported analysis highlight that anti-tumor adaptive T cell responses are potentially augmented in a subset of patients leading to lymphoma regression. In these patients, it is possible that “primed” innate anti-tumor T cell immunity is enhanced in immunogenic lymphoma subtypes after tissue biopsy. Our case and analysis not only reinforce the role of innate T cell anticancer immunity, but also originates potential proof of concept for investigation of unexplored pathways that could favorably impact T cell therapy. |
format | Online Article Text |
id | pubmed-6357409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63574092019-02-07 Spontaneous remission in diffuse large cell lymphoma: a case report Snijder, J. Mihyawi, N. Frolov, A. Ewton, A. Rivero, G. J Med Case Rep Case Report BACKGROUND: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission suggest that not yet fully characterized tumor-intrinsic and microenvironment mechanisms cooperate with spontaneous regression. CASE DESCRIPTION: Here, we report the case of an 88-year-old white woman with diffuse large b cell lymphoma (follicular lymphoma transformed) who achieved morphologic spontaneous remission 3 months after her diagnostic core biopsy. We examined 16 similar cases of diffuse large b cell lymphoma suggesting that spontaneous remission is preferentially observed in elderly patients soon after their biopsy microtrauma, especially if malignancies are Epstein–Barr virus driven and activated B-cell type. CONCLUSION: Our case and reported analysis highlight that anti-tumor adaptive T cell responses are potentially augmented in a subset of patients leading to lymphoma regression. In these patients, it is possible that “primed” innate anti-tumor T cell immunity is enhanced in immunogenic lymphoma subtypes after tissue biopsy. Our case and analysis not only reinforce the role of innate T cell anticancer immunity, but also originates potential proof of concept for investigation of unexplored pathways that could favorably impact T cell therapy. BioMed Central 2019-02-01 /pmc/articles/PMC6357409/ /pubmed/30709425 http://dx.doi.org/10.1186/s13256-018-1937-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Snijder, J. Mihyawi, N. Frolov, A. Ewton, A. Rivero, G. Spontaneous remission in diffuse large cell lymphoma: a case report |
title | Spontaneous remission in diffuse large cell lymphoma: a case report |
title_full | Spontaneous remission in diffuse large cell lymphoma: a case report |
title_fullStr | Spontaneous remission in diffuse large cell lymphoma: a case report |
title_full_unstemmed | Spontaneous remission in diffuse large cell lymphoma: a case report |
title_short | Spontaneous remission in diffuse large cell lymphoma: a case report |
title_sort | spontaneous remission in diffuse large cell lymphoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357409/ https://www.ncbi.nlm.nih.gov/pubmed/30709425 http://dx.doi.org/10.1186/s13256-018-1937-z |
work_keys_str_mv | AT snijderj spontaneousremissionindiffuselargecelllymphomaacasereport AT mihyawin spontaneousremissionindiffuselargecelllymphomaacasereport AT frolova spontaneousremissionindiffuselargecelllymphomaacasereport AT ewtona spontaneousremissionindiffuselargecelllymphomaacasereport AT riverog spontaneousremissionindiffuselargecelllymphomaacasereport |